Cargando…
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
BACKGROUND: The glyoxalase system including two thiol-dependent enzymes, glyoxalase I (Glo-I) and glyoxalase II, plays an important role in a ubiquitous metabolic pathway involved in cellular detoxification of cytotoxic 2-oxoaldehydes. Tumor cells have high glycolytic activity, leading to increased...
Autores principales: | Al-Balas, Qosay A, Hassan, Mohammad A, Al-Shar’i, Nizar A, Mhaidat, Nizar M, Almaaytah, Ammar M, Al-Mahasneh, Fatima M, Isawi, Israa H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993257/ https://www.ncbi.nlm.nih.gov/pubmed/27574401 http://dx.doi.org/10.2147/DDDT.S110997 |
Ejemplares similares
-
Generation of the First Structure-Based Pharmacophore Model Containing a Selective “Zinc Binding Group” Feature to Identify Potential Glyoxalase-1 Inhibitors
por: Al-Balas, Qosay, et al.
Publicado: (2012) -
Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
por: Al-Balas, Qosay A., et al.
Publicado: (2013) -
Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors
por: Al-Balas, Qosay A., et al.
Publicado: (2019) -
Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme
por: Al-Balas, Qosay A, et al.
Publicado: (2014) -
Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein
por: Mhaidat, Nizar M, et al.
Publicado: (2016)